Latest filing published 08 Jul 2024 for Edwards Lifesciences Corp, €6,993.
Filing timeline
BuySaleInsider track record
Jean-Luc M. Lemercier: trading record in brief
This profile gathers the share dealings of Jean-Luc M. Lemercier in Edwards Lifesciences Corp, where the filings describe the role as senior executive. Over a trading history stretching from 7 March 2018 to 7 July 2024, the count stands at 94 filings.
No open-market purchase appears, only 30 sales worth €20.0M. Besides market trades, the filings include 33 share grants and 31 option exercises. In 2024 alone, the filings show no purchases and 5 sales.
On 8 July 2024 came the latest disclosure, a share grant for €6,993 in Edwards Lifesciences Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jean-Luc M. Lemercier
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 82 shares@ US$92.320.3% of flowCommon StockSEC:0001225208-24-007359:0
- 21 shares@ US$86.720.1% of flowCommon StockSEC:0001225208-24-005982:0
- 46 shares@ US$85.090.0% of flowCommon StockSEC:0001225208-24-005888:1
- 7,125 shares0Common StockSEC:0001225208-24-005888:0
- 4,157 shares0Common StockSEC:0001225208-24-005702:1
- 259 shares@ US$85.250.1% of flowCommon StockSEC:0001225208-24-005702:2
- 37 shares@ US$85.060.1% of flowCommon StockSEC:0001225208-24-005702:0
- 2,160 shares@ US$84.830.7% of flowCommon StockSEC:0001225208-24-005437:1
- 12,240 shares@ US$84.113.8% of flowCommon StockSEC:0001225208-24-005437:2
- 14,400 shares@ US$36.7520.4% of flowCommon StockSEC:0001225208-24-005437:0
- 107 shares@ US$92.650.0% of flowCommon StockSEC:0001225208-24-005005:1
- 14,293 shares@ US$92.324.8% of flowCommon StockSEC:0001225208-24-005005:2
- 14,400 shares@ US$36.7520.1% of flowCommon StockSEC:0001225208-24-005005:0
- 14,400 shares@ US$91.684.7% of flowCommon StockSEC:0001225208-24-004035:1
- 14,400 shares@ US$36.7520.0% of flowCommon StockSEC:0001225208-24-004035:0
- 81 shares@ US$90.460.3% of flowCommon StockSEC:0001225208-23-007394:0
- 1,575 shares0Common StockSEC:0001225208-23-005917:0
- 224 shares@ US$88.740.1% of flowCommon StockSEC:0001225208-23-005617:1
- 104 shares@ US$88.740.0% of flowCommon StockSEC:0001225208-23-005617:2
- 6,640 shares@ US$35.200.8% of flowCommon StockSEC:0001225208-23-005617:3
- 6,640 shares@ US$88.682.1% of flowCommon StockSEC:0001225208-23-005617:4
- 3,355 shares0Common StockSEC:0001225208-23-005617:0
- 38 shares@ US$88.100.0% of flowCommon StockSEC:0001225208-23-005433:1
- 37 shares@ US$87.810.1% of flowCommon StockSEC:0001225208-23-005433:0
- 6,640 shares@ US$83.102.0% of flowCommon StockSEC:0001225208-23-004761:1
25 of 94 declarations
